Mouse Anti-CNTNAP4 Recombinant Antibody (CBCNC-236) (V2LY-1206-LY558)

Zhang, W., Zhou, M., Lu, W., Gong, J., Gao, F., Li, Y., ... & Zhang, Y. (2020). CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics, 10(7), 3000.

Ha, P., Luo, X., Li, C., Mok, J. W., Lee, S. S., Golnazarian, N. K., ... & Soo, C. (2019). Inactivation of Cntnap4 in Cranial Neural Crest Cells Results in Craniofacial Bone Deformities and Hydrocephalus. Plastic and Reconstructive Surgery–Global Open, 7(4S), 52-53.

Li, C., Zheng, Z., Ha, P., Chen, X., Jiang, W., Sun, S., ... & Soo, C. (2018). Neurexin Superfamily Cell Membrane Receptor Contactin‐Associated Protein Like‐4 (Cntnap4) Is Involved in Neural EGFL‐Like 1 (Nell‐1)‐Responsive Osteogenesis. Journal of Bone and Mineral Research, 33(10), 1813-1825.

Chen, E. (2018). Neurexin Family Member Contactin-Associated Protein Like-4 (CNTNAP4) is a specific cell membrane receptor of Neural EGFL Like 1 (NELL1) (Doctoral dissertation, UCLA).

Shangguan, Y., Xu, X., Ganbat, B., Li, Y., Wang, W., Yang, Y., ... & Wang, X. (2018). CNTNAP4 impacts epilepsy through GABAA receptors regulation: evidence from temporal lobe epilepsy patients and mouse models. Cerebral Cortex, 28(10), 3491-3504.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols